All filters
Slidesets
PrEP Rollout in Europe - Current Update - Pep Coll, MD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
PrEP - remaining community needs - Michael Meulbroek
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
What are the remaining challenges to improve the quality of life of people living HIV? - Michael Meulbroek
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
ChemSex - DDI interactions - Jose Molto, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
The relationship between the migration status and the Health-Related Quality of Life (HRQoL) of people living with HIV: a study on the Swedish InfcareHIV cohort from 2011 to 2017 - Gaetano Marrone
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Sexual Health Counseling - Shaun Watson
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Country specific factors determine the quality of life among people with HIV in two western European countries - Stephanie Popping, MD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
An online survey of the quality of life in patients with HIV-infection in Krasnodar - Maxim Konyukhov
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
HIV and Ageing – Primary and secondary prevention of coronary artery disease among People living with HIV - Gaetano Marrone
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Very low sensitivity of Fracture Risk Assessment Tool in young HIV-infected patients: The need for new screening strategies - Berend van Welzen, MD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Current status of HIV: the importance of comorbidities. Do we have to worry about the quality of life of our HIV patients? - Maria Jose Galindo
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Obesity and HIV Treatment - Knowns and unknowns - Laura Waters, MD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
e-Health solution characteristics for PLHIV: a Portuguese experience - Gonçalo Lobo
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Clinical implications of Long Acting Antivirals - Andrea Calcagno, MD
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Usability of a Mobile Health Application (“APP”) on Older HIV-Infected Patients: An Emerging Tool for Care, Education and Prevention - Jordi Puig Pla, RN
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Sexual health clinic-based delivery model - Rena Janamnuaysook, MBA
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Pharmacokinetics of tenofovir alafenamide 25 mg with PK boosters during pregnancy and postpartum - Kristina Brooks, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Infectious disease action plan for the global accelerator for paediatric formulations (GAP-f) - Paul Domanico, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Pharmacokinetics of atazanavir boosted with cobicistat during pregnancy and postpartum - Jeremiah Momper
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Infant exposure to dolutegravir through placental and breastmilk transfer: A population PK analysis of DolPHIN-1 - Laura Dickinson
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Low isoniazid concentrations in pregnant and postpartum women treated for tuberculosis irrespective of efavirenz-based ART co-treatment - Marije Van Schalkwyk, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Tenofovir-diphosphate in PBMC following increasing TAF vs. TDF dosing under directly observed therapy - Jenna Yager
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
An exploration of adherence measures to detect recent changes in Truvada® dosing patterns - Daijha Anderson
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Physiologically based pharmacokinetic modelling to determine pharmacokinetic alterations driving ritonavir exposure changes in aging people living with HIV - Felix Stader
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019